Cutler Group’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,500
Closed -$5K 4774
2022
Q4
$5K Hold
1,500
﹤0.01% 3225
2022
Q3
$5K Buy
1,500
+1,000
+200% +$4.74K ﹤0.01% 3706
2022
Q2
$3K Sell
500
-333
-40% -$1.79K ﹤0.01% 4123
2022
Q1
$5K Sell
833
-467
-36% -$1.96K ﹤0.01% 4183
2021
Q4
$7K Sell
1,300
-967
-43% -$7.07K ﹤0.01% 3991
2021
Q3
$10K Sell
2,267
-9,400
-81% -$106K ﹤0.01% 3960
2021
Q2
$36K Buy
+11,667
New +$225K ﹤0.01% 2778
2017
Q1
Sell
-42
Closed -$4K 7269
2016
Q4
$4K Sell
42
-91
-68% -$5.2K ﹤0.01% 5149
2016
Q3
$6K Buy
133
+108
+432% +$9.56K ﹤0.01% 4816
2016
Q2
$1K Sell
25
-488
-95% -$50.8K ﹤0.01% 6292
2016
Q1
$15K Buy
513
+330
+180% +$38K ﹤0.01% 3618
2015
Q4
$5K Buy
+183
New +$26.8K ﹤0.01% 4947

Other funds holding VANI

Cutler Group's VANI Position: Q4 2022 in Review

Cutler Group sold out of Vivani Medical (VANI) in Q4 2022, closing a stake of 366 shares — an estimated $596 sold.

Cutler Group first reported a position in VANI in Q4 2015 and held it in 11 quarters. The position peaked at $121K in Q2 2021. 35 funds tracked by Wall St. Rank hold VANI as of Q4 2022.

  • Cutler Group reported no remaining Vivani Medical position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 366 Vivani Medical shares in Q4 2022, an estimated $596.
  • Cutler Group first reported a position in Vivani Medical in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Vivani Medical position peaked at $121K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.